Professor Jonathan Green is Professor of Child & Adolescent Psychiatry in the University of Manchester and Honorary Consultant Child & Adolescent Psychiatrist at Central Manchester and Manchester Children’s Hospitals University NHS Trust and Manchester Biomedical Research Centre.

He serves on the Editorial/Advisory Boards of the Journal of Child Psychology and Psychiatry, Advances in Psychiatric Treatment and European Journal of Child & Adolescent Psychiatry, and is a member of the Commissioning Board for the NIHR Health Technology Assessment programme.  Other roles include - National Trials Adoptions Committee, UKCRN; Scientific Board, British Autism Study of Infant Siblings.

Jonathan Green did general medical training in Cambridge University and University College London; Paediatrics and Developmental Paediatrics at Queen Elizabeth Hospital for Children, Nuffield Hearing and Speech Centre and the Thomas Coram Research Centre in London; before specialising in Child Psychiatry in Oxford and then Manchester.

He has a long standing clinical and research interests in autism and other aspects of social development in children.

Clinically, he runs a regional specialist Social Development Clinic at the Royal Manchester Children’s Hospital, which undertakes assessment and treatment innovation with ASD and a range of other impairments of social development in children. He co-led the UK’s first study into ICD Asperger Syndrome and has published on social and language development in ASD, co-morbidity and treatment intervention, as well as on Attachment Disorder and the social development consequences of early attachment failure.

I am interested in the social development of children – and how problems in social development are central to many child mental health problems.

I lead the Social Development Research Group: for details see - http://www.bbmh.manchester.ac.uk/socialdevelopment

Within clinical trials work I collaborate with Richard Emsley and other methodologists and bio-statisticians in the MRC funded Manchester trials methodology research group headed by Professor Graham Dunn. Within this group we study treatment process in trials, therapeutic alliance (including the PhD projects Antecedents of Therapeutic Alliance and Therapeutic alliance personality and treatment outcome in group therapy) and new ways of analysing causal inferences in trial results. Within clinical genetics work with colleagues in Genomic Medicine, Sue Huson, Bronwyn Kerr; and in NeuroImaging, Stavros Stivaros, John Keane.

Child Mental Health, Autism, Attachment Disorders, Clinical Trials